Credit Suisse Upgrades Abaxis Inc. (ABAX) to Neutral Following Acquisition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Zoetis Inc. (ZTS) PT Raised to $82 at BMO Capital; Abaxis Deal Strong But Doesn't Change Thesis
May 17, 2018 1:06 PM EDTBMO Capital raised its price target on Zoetis Inc. (NYSE: ZTS) to $82.00 (from $80.00) while maintaining a Market Perform rating.
Analyst Alex Arfaei commented, "We have updated our model to include Abaxis acquisition. Overall, we see a strong strategic rationale for the... More
Zoetis (ZTS) to Acquire Abaxis (ABAX) for About $2 Billion
May 16, 2018 7:01 AM EDTZoetis Inc. (NYSE: ZTS) and Abaxis, Inc. (NASDAQ: ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate. The acquisition is expected to enhance Zoetis presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years1.
Abaxis, founded in 1989 and headquartered in Union City, Calif., is a... More
